Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ABIOMED stock

Learn how to easily invest in ABIOMED stock.

ABIOMED is a medical devices business based in the US. ABIOMED shares (ABMD) are listed on the NASDAQ and all prices are listed in US Dollars. ABIOMED employs 2,003 staff and has a trailing 12-month revenue of around $1.1 billion.

How to buy ABIOMED stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ABMD. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

ABIOMED stock price (NASDAQ: ABMD)

Use our graph to track the performance of ABMD stocks over time.

ABIOMED shares at a glance

Information last updated 2023-01-23.
Latest market close$0.00
52-week range$219.85 - $381.99
50-day moving average $351.42
200-day moving average $291.67
Wall St. target price$363.00
PE ratio 65.3551
Dividend yield $0 (0%)
Earnings per share (TTM) $5.83

Buy ABIOMED stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy ABIOMED stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ABIOMED price performance over time

Historical closes compared with the close of $0 from 2023-01-20

1 week (2023-01-22) nan%
1 month (2022-12-29) nan%
3 months (2022-11-02) -100.00%
6 months (2022-08-02) -100.00%
1 year (2022-02-02) -100.00%
2 years (2021-02-02) -100.00%
3 years (2020-01-31) 186.29
5 years (2018-02-02) 248.2

Is ABIOMED stock undervalued or overvalued?

Valuing ABIOMED stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ABIOMED's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ABIOMED's P/E ratio

ABIOMED's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, ABIOMED shares trade at around 65x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.


ABIOMED's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ABIOMED's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.


ABIOMED's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $274.2 million.

The EBITDA is a measure of a ABIOMED's overall financial performance and is widely used to measure a its profitability.

ABIOMED financials

Revenue TTM $1.1 billion
Operating margin TTM 22.96%
Gross profit TTM $843.6 million
Return on assets TTM 9.55%
Return on equity TTM 18.24%
Profit margin 24.84%
Book value $34.09
Market capitalisation $17.2 billion

TTM: trailing 12 months

ABIOMED share dividends

We're not expecting ABIOMED to pay a dividend over the next 12 months.

Have ABIOMED's shares ever split?

ABIOMED's shares were split on a 2:1 basis on 1 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ABIOMED shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ABIOMED shares which in turn could have impacted ABIOMED's share price.

ABIOMED share price volatility

Over the last 12 months, ABIOMED's shares have ranged in value from as little as $219.85 up to $381.99. A popular way to gauge a stock's volatility is its "beta".

ABMD.US volatility(beta: 1.4)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ABIOMED's is 1.3976. This would suggest that ABIOMED's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ABIOMED overview

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2. 5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5. 0, Impella LD, and Impella 5.

Frequently asked questions

What percentage of ABIOMED is owned by insiders or institutions?
Currently 2.024% of ABIOMED shares are held by insiders and 97.09% by institutions.
How many people work for ABIOMED?
Latest data suggests 2,003 work at ABIOMED.
When does the fiscal year end for ABIOMED?
ABIOMED's fiscal year ends in March.
Where is ABIOMED based?
ABIOMED's address is: 22 Cherry Hill Drive, Danvers, MA, United States, 01923
What is ABIOMED's ISIN number?
ABIOMED's international securities identification number is: US0036541003
What is ABIOMED's CUSIP number?
ABIOMED's Committee on Uniform Securities Identification Procedures number is: 003654100

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site